de-extinction

Dallas’ Colossal Foundation Donates $1M to Help Save Amphibians from Mass Extinction

by | Dec 17, 2024
“Helping to stop the spread of chytrid is a necessity to ensure healthy ecosystems globally,” said Colossal Foundation Director Matt James. “This isn’t optional. We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come."
MORE
Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More
by | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE
Colossal Biosciences Adds Renowned Ancient DNA Expert as Chief Science Officer
by | Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE

Hollywood Brand Veteran Takes CMO Helm at Colossal Biosciences to Bring De-Extinction to the Global Stage

by | Feb 2, 2024

Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties.

The bioscience and genetics startup achieved “unicorn” status about a year ago with a $150 million Series B fundraise and has made headlines for its plans to de-extinct the woolly mammoth, dodo bird, and Tasmanian tiger. ...

MORE
Colossal Biosciences, Vertebrate Genomes Project Publish First High-Quality Reference Genome of African Elephant
by | May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE